Medication and doping in equestrian sport creates welfare concerns by masking pain that would otherwise signal the need for rest or treatment.
Medication in equestrian sport intersects welfare and sport integrity: drugs that mask pain allow horses to perform through injury, causing further damage, while their use in competition distorts fair competition. The welfare concern is not therapeutic medication per se but the use of pain-masking drugs to enable performance that a horse in pain would not voluntarily continue. Soring represents the extreme end of this spectrum — deliberately causing pain to produce gait characteristics — but less dramatic pain masking through joint injections before competition raises similar welfare principles at scale. Sport governance that takes welfare seriously must address not just prohibited performance-enhancing substances but pain masking that enables competition by horses who, absent medication, could not perform comfortably.